clinical trial tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity Tirzepatide in Adults With Type

[21] The medication undergoes extensive first-pass metabolism in the liver, with less than 5% of the drug remaining unchanged in plasma following oral administration

Lipoatrophy, the opposite condition involving loss of fatty tissue at injection sites, occurs less commonly but can happen with any injectable medication

Most commonly, these tablets are round or oval and come in colors such as white, pink, or light purple, depending on the manufacturer

Their high cost, broad potential use, and long-term treatment needs are creating significant financial concerns for employers covering these drugs for weight management

Cosmetic benefits from filler injection are long-lasting